European Journal of Dermatology
MENUPediatric primary cutaneous marginal zone B-cell lymphoma treated with intralesional rituximab Volume 20, numéro 4, July-August 2010
Illustrations
Department of Dermatology, Department of Pediatrics, Ajou University School of Medicine, 5 Wonchon-Dong, Yeongtong-Gu, Suwon 443-721, South Korea
- DOI : 10.1684/ejd.2010.0987
- Page(s) : 533-4
- Année de parution : 2010
Auteur(s) : Min Young Park1, Hyun Joo Jung2, Jun Eun Park2, You Chan Kim1 1Department of Dermatology 2Department of Pediatrics, Ajou University School of Medicine, 5 Wonchon-Dong, Yeongtong-Gu, Suwon 443-721, South Korea Primary cutaneous marginal zone B-cell lymphoma (PCMZL) is an indolent lymphoma which is extremely rare in children. Recently, intralesional therapy with anti-CD20 monoclonal antibodies (rituximab) has shown favorable results for the treatment [...]